Pfizer Says Coronavirus Vaccine Could Be Ready for FDA Review by End of November

Pharmaceutical giant Pfizer has put the kibosh on any dreams of rushing out its experimental covid-19 vaccine before the U.S. election day. The good news is that the company is optimistic that its vaccine will be ready to apply for the Food and Drug Administration’s emergency use authorization (EUA) by the end of…

Read more…

via Gizmodo

Check out the Finding Your Identity Podcast